Sort
23,748 grants matching “melanoma”
Function of ATF2 URE Binding Protein in Human Melanoma
$391,867Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2007 · CA
The lymph node microenvionment in tumor metastasis
$391,838Judith A. Varner · University Of California, San Diego · R01 · FY2011 · CA
Molecule-Guided Investigations into p53 Biology
$391,777Federico Bernal · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
DEVELOPMENT OF RATIONAL COMBINATION THERAPY STRATEGIES FOR THE TREATMENT OF METASTATIC MELANOMA
$391,766The Royal Institution For The Advancement Of Learning · · FY2015 · Department of Defense
(PQ5) Mitochondria are endocellular symbionts that serve as targets for immune recognition
$391,766Andrea Facciabene · University Of Pennsylvania · R01 · FY2019 · CA
Project 3: Inhibiting Oxidative Phosphorylation in Pancreatic Cancer
$391,697Shubham Pant · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
Establishing the clinical utility of cell-free tumor DNA methylation profiling as a reliable liquid biopsy approach in brain tumors
$391,675Gelareh Zadeh · University Health Network · R01 · FY2025 · CA
Molecular Pathophysiology of Thyroid Cell Growth
$391,600James A Fagin · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA
Molecular Pathophysiology of Thyroid Cell Growth
$391,600James A Fagin · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Preventing Melanoma Metastasis by Targeting Lipid Vulnerabilities in Lymph
$391,523Jessalyn Ubellacker · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2025 · CA
Preclinical Study of Peptide Based Human Tumor Vaccines
$391,471Victor H. Engelhard · University Of Virginia · R01 · FY2007 · CA
Synergy of the innate and acquired immune responses in tumor immunology
$391,469Randolph J. Noelle · Dartmouth College · R01 · FY2009 · CA
Establishing MAGE-A4/RAD18 as a novel cancer-specific chemotherapeutic target
$391,466Cyrus Vaziri · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
The lymph node microenvionment in tumor metastasis
$391,453Judith A. Varner · University Of California, San Diego · R01 · FY2012 · CA
Preclinical Study of Peptide Based Human Tumor Vaccines
$391,420Victor H. Engelhard · University Of Virginia · R01 · FY2006 · CA
Pilot Projects and Trans-Network Activities Core
$391,385Meenhard Herlyn · Wistar Institute · U54 · FY2019 · CA
Targeting the colchicine site in tubulin for advanced melanoma
$391,361Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2016 · CA
Reprogramming the Tumor Microenvironment to Improve Immunotherapy of Glioblastoma by Co-Targeting VEGF and Ang2
$391,317Dai Fukumura · Massachusetts General Hospital · R01 · FY2024 · NS
ACADEMIC CLINICAL ONCOLOGIST TRAINING PROGRAM
$391,285University Of Wisconsin Madison · K12 · FY2002 · CA
ILT3 (LILRB4) in anti-tumor immunity and immunotherapy
$391,277Marco Colonna · Washington University · R21 · FY2024 · CA
Identification of T Cell-Defined Antigens in Ovarian Cancer
$391,253Cassian Yee · Fred Hutchinson Cancer Research Center · R33 · FY2010 · CA
CANCER AND LEUKEMIA GROUP B
$391,239Dana-Farber Cancer Institute · U10 · FY2001 · CA
Patterning of the Vertebrate Nervous System
$391,134Sergei Y Sokol · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · NS
Integration of neo-antigen vaccines and immune checkpoint therapy
$391,107Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2025 · CA
Integration of neo-antigen vaccines and immune checkpoint therapy
$391,107Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2021 · CA